Time-course profile of urinary excretion of intravenously administered α-pyrrolidinovalerophenone and α-pyrrolidinobutiophenone in a human

Forensic Toxicology

Volumn 32, Issue 1, 2014, Pages 68-74

  Namera, Akira ^a   Konuma, Kyohei ^b   Kawamura, Maho ^c   Saito, Takeshi ^d   Nakamoto, Akihiro ^c   Yahata, Midori ^c   Ohta, Shigenori ^e   Miyazaki, Shota ^e   Shiraishi, Hiroaki ^a   Nagao, Masataka ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Konuma Memorial Institute of Drug Dependence   (Japan)

^c Forensic Science Laboratory   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e GL SCIENCES INC   (Japan)

Author keywords

PBP; PVP; Excretion half life; GC MS; Human; Urine analysis

Indexed keywords

EID: 84895144130     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-013-0203-8     Document Type: Article

References (21)

1. EMCDDA (2013) European drug report 2013: trends and developments. European Monitoring Centre for Drugs and Drug Addiction. http://www.emcdda. europa.eu/publications/edr/trends-developments/2013. Accessed 5 July 2013
2. United Nations (2012) World drug report 2012. United Nations Office on Drugs and Crime. http://www.unodc.org/unodc/en/data-and-analysis/WDR-2012.html. Accessed 5 July 2013
3. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2013) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 31:44-53
4. Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2012) Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3- carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicol 30:114-125
5. Meyer MR, Peters FT (2012) Analytical toxicology of emerging drugs of abuse - an update. Ther Drug Monit 34:615-621
6. Zuba D, Geppert B, Sekuła K, Åaba C (2013) [1-(Tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl) methanone: a new synthetic cannabinoid identified on the drug market. Forensic Toxicol 31:281-291
7. Kelly JP (2011) Cathinone derivatives: a review of their chemistry, pharmacology and toxicology. Drug Test Anal 3:439-453
8. Coppola M, Mondola R (2012) 3,4-Methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. Toxicol Lett 208:12-15
9. Meyer MR, Maurer HH (2010) Metabolism of designer drugs of abuse: an updated review. Curr Drug Metab 11:468-482
10. Ojanperä IA, Heikman PK, Rasanen IJ (2011) Urine analysis of 3,4-methylenedioxypyrovalerone in opioid-dependent patients by gas chromatography-mass spectrometry. Ther Drug Monit 33:257-263
11. Shima N, Katagi M, Kamata H, Matsuta S, Nakanishi K, Zaitsu K, Kamata T, Nishioka H, Miki A, Tatsuno M, Sato T, Tsuchihashi H, Suzuki K (2013) Urinary excretion and metabolism of the newly encountered designer drug 3,4-dimethylmethcathinone in humans. Forensic Toxicol 31:101-112
12. Toennes SW, Kauert GF (2002) Excretion and detection of cathinone, cathine, and phenylpropanolamine in urine after khat chewing. Clin Chem 48:1715-1719
13. Toennes SW, Harder S, Schramm M, Niess C, Kauert GF (2003) Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br J Clin Pharmacol 56:125-130
14. 9-tetrahydrocannabinol-9-carboxylic acid from a limited volume of urine using a monolithic silica spin column coupled with gas chromatography-mass spectrometry. Forensic Toxicol 31:312-321
15. 18 monolithic spin-column extraction and GC-MS for simultaneous assay of organophosphorus compounds, glyphosate, and glufosinate in human serum and urine. Forensic Toxicol 30:1-10
16. Guidance for industry bioanalytical method validation. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm070107.pdf. Accessed 6 July 2013
17. Wang CC, Hartmann-Fischbach P, Krueger TR, Wells TL, Feineman AR, Compton JC (2012) Rapid and sensitive analysis of 3,4-methylenedioxypyrovalerone in equine plasma using liquid chromatography-tandem mass spectrometry. J Anal Toxicol 36:327-333
18. Wissenbach DK, Meyer MR, Remane D, Philipp AA, Weber AA, Maurer HH (2011) Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept. Anal Bioanal Chem 400:3481-3489
19. Sauer C, Peters FT, Haas C, Meyer MR, Fritschi G, Maurer HH (2009) New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J Mass Spectrom 44:952-964
20. Ullrich KJ, Papavassiliou F, David C, Rumrich G, Fritzsch G (1991) Contraluminal transport of organic cations in the proximal tubule of the rat kidney. Pflugers Arch 419:84-92
21. Beckett AH, Rowland M (1965) Urinary excretion kinetics of methamphetamine in man. J Pharm Pharmacol 17:109S-114S